1. Home
  2. CGEN vs BOOM Comparison

CGEN vs BOOM Comparison

Compare CGEN & BOOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEN
  • BOOM
  • Stock Information
  • Founded
  • CGEN 1993
  • BOOM 1965
  • Country
  • CGEN Israel
  • BOOM United States
  • Employees
  • CGEN N/A
  • BOOM N/A
  • Industry
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • BOOM Industrial Specialties
  • Sector
  • CGEN Health Care
  • BOOM Industrials
  • Exchange
  • CGEN Nasdaq
  • BOOM Nasdaq
  • Market Cap
  • CGEN 125.3M
  • BOOM 127.5M
  • IPO Year
  • CGEN 2000
  • BOOM N/A
  • Fundamental
  • Price
  • CGEN $1.58
  • BOOM $6.06
  • Analyst Decision
  • CGEN
  • BOOM Hold
  • Analyst Count
  • CGEN 0
  • BOOM 1
  • Target Price
  • CGEN N/A
  • BOOM $8.50
  • AVG Volume (30 Days)
  • CGEN 522.7K
  • BOOM 178.7K
  • Earning Date
  • CGEN 11-10-2025
  • BOOM 11-04-2025
  • Dividend Yield
  • CGEN N/A
  • BOOM N/A
  • EPS Growth
  • CGEN N/A
  • BOOM N/A
  • EPS
  • CGEN N/A
  • BOOM N/A
  • Revenue
  • CGEN $22,144,000.00
  • BOOM $618,683,000.00
  • Revenue This Year
  • CGEN N/A
  • BOOM N/A
  • Revenue Next Year
  • CGEN $208.08
  • BOOM $2.70
  • P/E Ratio
  • CGEN N/A
  • BOOM N/A
  • Revenue Growth
  • CGEN N/A
  • BOOM N/A
  • 52 Week Low
  • CGEN $1.13
  • BOOM $5.78
  • 52 Week High
  • CGEN $2.66
  • BOOM $9.92
  • Technical
  • Relative Strength Index (RSI)
  • CGEN 44.43
  • BOOM 28.25
  • Support Level
  • CGEN $1.61
  • BOOM $6.14
  • Resistance Level
  • CGEN $1.80
  • BOOM $8.60
  • Average True Range (ATR)
  • CGEN 0.11
  • BOOM 0.37
  • MACD
  • CGEN -0.03
  • BOOM -0.25
  • Stochastic Oscillator
  • CGEN 19.35
  • BOOM 5.59

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

About BOOM DMC Global Inc.

DMC Global Inc operates a diversified family of technical product and process businesses serving the energy, industrial and infrastructure markets. Its business is organized into three segments: Arcadia, DynaEnergetics, and NobelClad. Arcadia Products supplies architectural building products, including exterior and interior framing systems, windows, urtain walls, storefronts etc to the commercial construction market. NobelClad is involved in the production of explosion-welded clad metal plates for use in the construction of corrosion-resistant industrial processing equipment and specialized transition joints. DynaEnergetics driver, designs manufactures and distributes products utilized by the oil and gas industry principally for the perforation of oil and gas wells.

Share on Social Networks: